BTIG Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $25

BTIG analyst Marie Thibault has initiated coverage on Minimed Group (NASDAQ: MMED) with a Buy rating. The firm has set a price target of $25 for the company's stock.